Antibody Response to CoronaVac Vaccine in Indonesian COVID-19 Survivor

Rahmat Azhari Kemal, Dita Kartika Sari, Ariza Julia Paulina
doi: https://doi.org/10.1101/2021.05.28.21254613

Article Information

doi 
https://doi.org/10.1101/2021.05.28.21254613
History 
  • May 29, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.

Author Information

  1. Rahmat Azhari Kemal1,*,
  2. Dita Kartika Sari2 and
  3. Ariza Julia Paulina3
  1. 1Department of Medical Biology, Faculty of Medicine, Universitas Riau, Pekanbaru, Indonesia; and Biomolecular Laboratory, Arifin Achmad General Hospital of Riau Province, Pekanbaru, Indonesia
  2. 2Department of Anatomy, Faculty of Medicine, Universitas Riau, Pekanbaru, Indonesia
  3. 3Department of Clinical Pathology, Faculty of Medicine, Universitas Riau, Pekanbaru, Indonesia
  1. ↵*Address for correspondence
    : Rahmat A. Kemal, Department of Medical Biology, Faculty of Medicine, Universitas Riau, Jl. Diponegoro no. 1, Pekanbaru, Riau, Indonesia, 28133; email: rahmat.azharikemal{at}lecturer.unri.ac.id; phone/fax: +62761 83926
Back to top
Posted May 29, 2021.
Download PDF
Data/Code
Email
Antibody Response to CoronaVac Vaccine in Indonesian COVID-19 Survivor
Rahmat Azhari Kemal, Dita Kartika Sari, Ariza Julia Paulina
medRxiv 2021.05.28.21254613; doi: https://doi.org/10.1101/2021.05.28.21254613
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area